Zosano Pharma Shares Outstanding 2013-2021 | ZSAN

Zosano Pharma shares outstanding from 2013 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Zosano Pharma Annual Shares Outstanding
(Millions of Shares)
2020 68
2019 16
2018 9
2017 2
2016 1
2015 1
2014 0
2013 0
2012 0
Zosano Pharma Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 109
2021-03-31 104
2020-12-31 68
2020-09-30 78
2020-06-30 55
2020-03-31 36
2019-12-31 16
2019-09-30 18
2019-06-30 17
2019-03-31 12
2018-12-31 9
2018-09-30 12
2018-06-30 12
2018-03-31 2
2017-12-31 2
2017-09-30 39
2017-06-30 2
2017-03-31 1
2016-12-31 1
2016-09-30 1
2016-06-30 1
2016-03-31 1
2015-12-31 1
2015-09-30 1
2015-06-30 1
2015-03-31 0
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.081B $0.000B
Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71